img

Global Rituximab Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Rituximab Market Research Report 2024

Rituximab is a type of antibody therapy that can be used alone or with chemotherapy.
According to Mr Accuracy reports new survey, global Rituximab market is projected to reach US$ 6006.3 million in 2029, increasing from US$ 10350 million in 2022, with the CAGR of -5.2% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Rituximab market research.
Revlimid, an oral medication used in the treatment of multiple myeloma and other blood cancers, is experiencing increasing demand. Factors driving market growth include the rising incidence of blood cancers, advancements in treatment options, and the expanding geriatric population. Key players in the market are focusing on expanding the indications of Revlimid and conducting clinical trials for new indications. Additionally, strategic collaborations and mergers are contributing to market expansion. However, challenges such as patent expirations and the availability of generic alternatives may impact market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Rituximab market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Roche
Pfizer
Biogen
Teva
Segment by Type
500mg
100mg

Segment by Application


Intravenous Use
Subcutaneous Use

Consumption by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Rituximab report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Rituximab Market Overview
1.1 Product Overview and Scope of Rituximab
1.2 Rituximab Segment by Type
1.2.1 Global Rituximab Market Value Comparison by Type (2024-2034)
1.2.2 500mg
1.2.3 100mg
1.3 Rituximab Segment by Application
1.3.1 Global Rituximab Market Value by Application: (2024-2034)
1.3.2 Intravenous Use
1.3.3 Subcutaneous Use
1.4 Global Rituximab Market Size Estimates and Forecasts
1.4.1 Global Rituximab Revenue 2018-2029
1.4.2 Global Rituximab Sales 2018-2029
1.4.3 Global Rituximab Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Rituximab Market Competition by Manufacturers
2.1 Global Rituximab Sales Market Share by Manufacturers (2018-2024)
2.2 Global Rituximab Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Rituximab Average Price by Manufacturers (2018-2024)
2.4 Global Rituximab Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Rituximab, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rituximab, Product Type & Application
2.7 Rituximab Market Competitive Situation and Trends
2.7.1 Rituximab Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Rituximab Players Market Share by Revenue
2.7.3 Global Rituximab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Rituximab Retrospective Market Scenario by Region
3.1 Global Rituximab Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Rituximab Global Rituximab Sales by Region: 2018-2029
3.2.1 Global Rituximab Sales by Region: 2018-2024
3.2.2 Global Rituximab Sales by Region: 2024-2029
3.3 Global Rituximab Global Rituximab Revenue by Region: 2018-2029
3.3.1 Global Rituximab Revenue by Region: 2018-2024
3.3.2 Global Rituximab Revenue by Region: 2024-2029
3.4 North America Rituximab Market Facts & Figures by Country
3.4.1 North America Rituximab Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Rituximab Sales by Country (2018-2029)
3.4.3 North America Rituximab Revenue by Country (2018-2029)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Rituximab Market Facts & Figures by Country
3.5.1 Europe Rituximab Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Rituximab Sales by Country (2018-2029)
3.5.3 Europe Rituximab Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rituximab Market Facts & Figures by Country
3.6.1 Asia Pacific Rituximab Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Rituximab Sales by Country (2018-2029)
3.6.3 Asia Pacific Rituximab Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Rituximab Market Facts & Figures by Country
3.7.1 Latin America Rituximab Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Rituximab Sales by Country (2018-2029)
3.7.3 Latin America Rituximab Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rituximab Market Facts & Figures by Country
3.8.1 Middle East and Africa Rituximab Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Rituximab Sales by Country (2018-2029)
3.8.3 Middle East and Africa Rituximab Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rituximab Sales by Type (2018-2029)
4.1.1 Global Rituximab Sales by Type (2018-2024)
4.1.2 Global Rituximab Sales by Type (2024-2029)
4.1.3 Global Rituximab Sales Market Share by Type (2018-2029)
4.2 Global Rituximab Revenue by Type (2018-2029)
4.2.1 Global Rituximab Revenue by Type (2018-2024)
4.2.2 Global Rituximab Revenue by Type (2024-2029)
4.2.3 Global Rituximab Revenue Market Share by Type (2018-2029)
4.3 Global Rituximab Price by Type (2018-2029)
5 Segment by Application
5.1 Global Rituximab Sales by Application (2018-2029)
5.1.1 Global Rituximab Sales by Application (2018-2024)
5.1.2 Global Rituximab Sales by Application (2024-2029)
5.1.3 Global Rituximab Sales Market Share by Application (2018-2029)
5.2 Global Rituximab Revenue by Application (2018-2029)
5.2.1 Global Rituximab Revenue by Application (2018-2024)
5.2.2 Global Rituximab Revenue by Application (2024-2029)
5.2.3 Global Rituximab Revenue Market Share by Application (2018-2029)
5.3 Global Rituximab Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Rituximab Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Roche Rituximab Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Rituximab Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Pfizer Rituximab Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Biogen
6.3.1 Biogen Corporation Information
6.3.2 Biogen Description and Business Overview
6.3.3 Biogen Rituximab Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Biogen Rituximab Product Portfolio
6.3.5 Biogen Recent Developments/Updates
6.4 Teva
6.4.1 Teva Corporation Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Rituximab Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Teva Rituximab Product Portfolio
6.4.5 Teva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rituximab Industry Chain Analysis
7.2 Rituximab Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rituximab Production Mode & Process
7.4 Rituximab Sales and Marketing
7.4.1 Rituximab Sales Channels
7.4.2 Rituximab Distributors
7.5 Rituximab Customers
8 Rituximab Market Dynamics
8.1 Rituximab Industry Trends
8.2 Rituximab Market Drivers
8.3 Rituximab Market Challenges
8.4 Rituximab Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Rituximab Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Rituximab Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Rituximab Market Competitive Situation by Manufacturers in 2022
Table 4. Global Rituximab Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Rituximab Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Rituximab Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Rituximab Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Rituximab Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Rituximab, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Rituximab, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Rituximab, Product Type & Application
Table 12. Global Key Manufacturers of Rituximab, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Rituximab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rituximab as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Rituximab Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Rituximab Sales by Region (2018-2024) & (K Units)
Table 18. Global Rituximab Sales Market Share by Region (2018-2024)
Table 19. Global Rituximab Sales by Region (2024-2029) & (K Units)
Table 20. Global Rituximab Sales Market Share by Region (2024-2029)
Table 21. Global Rituximab Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Rituximab Revenue Market Share by Region (2018-2024)
Table 23. Global Rituximab Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Rituximab Revenue Market Share by Region (2024-2029)
Table 25. North America Rituximab Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Rituximab Sales by Country (2018-2024) & (K Units)
Table 27. North America Rituximab Sales by Country (2024-2029) & (K Units)
Table 28. North America Rituximab Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Rituximab Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Rituximab Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Rituximab Sales by Country (2018-2024) & (K Units)
Table 32. Europe Rituximab Sales by Country (2024-2029) & (K Units)
Table 33. Europe Rituximab Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Rituximab Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Rituximab Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Rituximab Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Rituximab Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Rituximab Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Rituximab Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Rituximab Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Rituximab Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Rituximab Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Rituximab Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Rituximab Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Rituximab Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Rituximab Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Rituximab Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Rituximab Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Rituximab Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Rituximab Sales (K Units) by Type (2018-2024)
Table 51. Global Rituximab Sales (K Units) by Type (2024-2029)
Table 52. Global Rituximab Sales Market Share by Type (2018-2024)
Table 53. Global Rituximab Sales Market Share by Type (2024-2029)
Table 54. Global Rituximab Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Rituximab Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Rituximab Revenue Market Share by Type (2018-2024)
Table 57. Global Rituximab Revenue Market Share by Type (2024-2029)
Table 58. Global Rituximab Price (USD/Unit) by Type (2018-2024)
Table 59. Global Rituximab Price (USD/Unit) by Type (2024-2029)
Table 60. Global Rituximab Sales (K Units) by Application (2018-2024)
Table 61. Global Rituximab Sales (K Units) by Application (2024-2029)
Table 62. Global Rituximab Sales Market Share by Application (2018-2024)
Table 63. Global Rituximab Sales Market Share by Application (2024-2029)
Table 64. Global Rituximab Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Rituximab Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Rituximab Revenue Market Share by Application (2018-2024)
Table 67. Global Rituximab Revenue Market Share by Application (2024-2029)
Table 68. Global Rituximab Price (USD/Unit) by Application (2018-2024)
Table 69. Global Rituximab Price (USD/Unit) by Application (2024-2029)
Table 70. Roche Corporation Information
Table 71. Roche Description and Business Overview
Table 72. Roche Rituximab Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Roche Rituximab Product
Table 74. Roche Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Rituximab Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. Pfizer Rituximab Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Biogen Corporation Information
Table 81. Biogen Description and Business Overview
Table 82. Biogen Rituximab Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 83. Biogen Rituximab Product
Table 84. Biogen Recent Developments/Updates
Table 85. Teva Corporation Information
Table 86. Teva Description and Business Overview
Table 87. Teva Rituximab Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 88. Teva Rituximab Product
Table 89. Teva Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Rituximab Distributors List
Table 93. Rituximab Customers List
Table 94. Rituximab Market Trends
Table 95. Rituximab Market Drivers
Table 96. Rituximab Market Challenges
Table 97. Rituximab Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Rituximab
Figure 2. Global Rituximab Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Rituximab Market Share by Type in 2022 & 2029
Figure 4. 500mg Product Picture
Figure 5. 100mg Product Picture
Figure 6. Global Rituximab Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Rituximab Market Share by Application in 2022 & 2029
Figure 8. Intravenous Use
Figure 9. Subcutaneous Use
Figure 10. Global Rituximab Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Rituximab Market Size (2018-2029) & (US$ Million)
Figure 12. Global Rituximab Sales (2018-2029) & (K Units)
Figure 13. Global Rituximab Average Price (USD/Unit) & (2018-2029)
Figure 14. Rituximab Report Years Considered
Figure 15. Rituximab Sales Share by Manufacturers in 2022
Figure 16. Global Rituximab Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Rituximab Players: Market Share by Revenue in 2022
Figure 18. Rituximab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Rituximab Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Rituximab Sales Market Share by Country (2018-2029)
Figure 21. North America Rituximab Revenue Market Share by Country (2018-2029)
Figure 22. the United States Rituximab Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Rituximab Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Rituximab Sales Market Share by Country (2018-2029)
Figure 25. Europe Rituximab Revenue Market Share by Country (2018-2029)
Figure 26. Germany Rituximab Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Rituximab Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. UK Rituximab Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Rituximab Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Rituximab Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Rituximab Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Rituximab Revenue Market Share by Region (2018-2029)
Figure 33. China Rituximab Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Rituximab Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Rituximab Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Rituximab Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Rituximab Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Rituximab Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Rituximab Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Rituximab Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Rituximab Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Rituximab Sales Market Share by Country (2018-2029)
Figure 43. Latin America Rituximab Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Rituximab Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Rituximab Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Rituximab Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Rituximab Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Rituximab Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Rituximab Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Rituximab Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Rituximab Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Rituximab by Type (2018-2029)
Figure 53. Global Revenue Market Share of Rituximab by Type (2018-2029)
Figure 54. Global Rituximab Price (USD/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Rituximab by Application (2018-2029)
Figure 56. Global Revenue Market Share of Rituximab by Application (2018-2029)
Figure 57. Global Rituximab Price (USD/Unit) by Application (2018-2029)
Figure 58. Rituximab Value Chain
Figure 59. Rituximab Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed